Initial Failure in Myoblast Transplantation Therapy Has Led the Way Toward the Isolation of Muscle Stem Cells: Potential for Tissue Regeneration

Current Topics in Developmental Biology

Volumn 68, Issue , 2005, Pages 263-280

  Urish, Kenneth ^a,b   Kanda, Yasunari ^b   Huard, Johnny ^a,b,c,d  

^a University of Pittsburgh   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL MUSCULAR DYSTROPHY; CELL SEPARATION; CYTOLOGY; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; MOUSE; MULTIPOTENT STEM CELL; MYOBLAST; PHYSIOLOGY; REGENERATION; REVIEW; SKELETAL MUSCLE; TISSUE ENGINEERING; TRANSPLANTATION; TREATMENT FAILURE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CELL SEPARATION; HUMANS; MICE; MICE, INBRED MDX; MULTIPOTENT STEM CELLS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS, SKELETAL; REGENERATION; TISSUE ENGINEERING; TREATMENT FAILURE;

EID: 25144463144     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(05)68009-X     Document Type: Review

References (99)

1. Arahata K., Ishiura S., Ishiguro T., Tsukahara T., Suhara Y., Eguchi C., Ishihara T., Nonaka I., Ozawa E., and Sugita H. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 333 (1988) 861-863
2. Baroffio A., Hamann M., Bernheim L., Bochaton-Piallat M.L., Gabbiani G., and Bader C.R. Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells. Differentiation 60 (1996) 47-57
3. Beauchamp J.R., Morgan J.E., Pagel C.N., and Partridge T.A. Quantitative studies of efficacy of myoblast transplantation. Muscle Nerve 18 Suppl. (1994) 261
4. Beauchamp J.R., Morgan J.E., Pagel C.N., and Partridge T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144 (1999) 1113-1122
5. Beauchamp J.R., Heslop L., Yu D.S., Tajbakhsh S., Kelly R.G., Wernig A., Buckingham M.E., Partridge T.A., and Zammit P.S. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J. Cell Biol. 151 (2000) 1221-1234
6. Bischoff R. Chemotaxis of skeletal muscle satellite cells. Dev. Dyn. 208 (1997) 505-515
7. Bittner R.E., Streubel B., Shorny S., Schaden G., Voit T., and Hoger H. Coisogenic all-plus-one immunization: A model for identifying missing proteins in null-mutant conditions. Antibodies to dystrophin in mdx mouse after transplantation of muscle from normal coisogenic donor. Neuropediatrics 25 (1994) 176-182
8. Bonilla E., Samitt C.E., Miranda A.F., Hays A.P., Salviati G., DiMauro S., Kunkel L.M., Hoffman E.P., and Rowland L.P. Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface. Cell 54 (1988) 447-452
9. Bosch P., Musgrave D., Ghivizzani S., Latterman C., Day C.S., and Huard J. The efficiency of muscle-derived cell-mediated bone formation. Cell Transplant. 9 (2000) 463-470
10. Boulanger A., Asselin I., Roy R., and Tremblay J.P. Role of non-major histocompatibility complex antigens in the rejection of transplanted myoblasts. Transplantation 63 (1997) 893-899
11. Cao B., Zheng B., Jankowski R.J., Kimura S., Ikezawa M., Deasy B., Cummins J., Epperly M., Qu-Petersen Z., and Huard J. Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat. Cell Biol. 5 (2003) 640-646
12. Caron N.J., Asselin I., Morel G., and Tremblay J.P. Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice. Cell Transplant. 8 (1999) 465-476
13. Cornelison D.D., and Wold B.J. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191 (1997) 270-283
14. Dai Y., Roman M., Naviaux R.K., and Verma I.M. Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89 (1992) 10892-10895
15. Deasy B.M., Jankowski R.J., and Huard J. Muscle-derived stem cells: Characterization and potential for cell-mediated therapy. Blood Cells Mol. Dis. 27 (2001) 924-933
16. Deasy B.M., Qu-Peterson Z., Greenberger J.S., and Huard J. Mechanisms of muscle stem cell expansion with cytokines. Stem Cells 20 (2002) 50-60
17. Deasy B.M., Jankowski R.J., Payne T.R., Cao B., Goff J.P., Greenberger J.S., and Huard J. Modeling stem cell population growth: Incorporating terms for proliferative heterogeneity. Stem Cells 21 (2003) 536-545
18. El Fahime E., Torrente Y., Caron N.J., Bresolin M.D., and Tremblay J.P. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp. Cell Res. 258 (2000) 279-287
19. Ervasti J.M., and Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell 66 (1991) 1121-1131
20. Fan Y., Maley M., Beilharz M., and Grounds M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19 (1996) 853-860
21. Ferrer A., Wells K.E., and Wells D.J. Immune responses to dystropin: Implications for gene therapy of Duchenne muscular dystrophy. Gene Ther. 7 (2000) 1439-1446
22. Goldring K., Partridge T., and Watt D. Muscle stem cells. J. Pathol. 197 (2002) 457-467
23. Gross J.G., and Morgan J.E. Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury. Muscle Nerve 22 (1999) 174-185
24. Grounds M.D., and McGeachie J.K. A model of myogenesis in vivo, derived from detailed autoradiographic studies of regenerating skeletal muscle, challenges the concept of quantal mitosis. Cell Tissue Res. 250 (1987) 563-569
25. Grounds M.D. Commentary on the present state of knowledge for myoblast transfer therapy. Cell Transplant. 5 (1996) 431-433
26. Guerette B., Asselin I., Vilquin J.T., Roy R., and Tremblay J.P. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve 18 (1995) 39-51
27. Guerette B., Asselin I., Skuk D., Entman M., and Tremblay J.P. Control of inflammatory damage by anti-LFA-1: Increase success of myoblast transplantation. Cell Transplant. 6 (1997) 101-107
28. Gussoni E., Pavlath G.K., Lanctot A.M., Sharma K.R., Miller R.G., Steinman L., and Blau H.M. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356 (1992) 435-438
29. Gussoni E., Blau H.M., and Kunkel L.M. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. 3 (1997) 970-977
30. Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., Kunkel L.M., and Mulligan R.C. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401 (1999) 390-394
31. Heslop L., Morgan J.E., and Partridge T.A. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J. Cell Sci. 113 Pt. 12 (2000) 2299-2308
32. Hoffman E.P., Brown Jr. R.H., and Kunkel L.M. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51 (1987) 919-928
33. Huard J., Bouchard J.P., Roy R., Labrecque C., Dansereau G., Lemieux B., and Tremblay J.P. Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy. Clin. Sci. (Lond.) 81 (1991) 287-288
34. Huard J., Labrecque C., Dansereau G., Robitaille L., and Tremblay J.P. Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts. Muscle Nerve 14 (1991) 178-182
35. Huard J., Bouchard J.P., Roy R., Malouin F., Dansereau G., Labrecque C., Albert N., Richards C.L., Lemieux B., and Tremblay J.P. Human myoblast transplantation: Preliminary results of 4 cases. Muscle Nerve 15 (1992) 550-560
36. Huard J., Roy R., Bouchard J.P., Malouin F., Richards C.L., and Tremblay J.P. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc. 24 (1992) 3049-3051
37. Huard J., Roy R., Guerette B., Verreault S., Tremblay G., and Tremblay J.P. Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection. Muscle Nerve 17 (1994) 224-234
38. Huard J., Verreault S., Roy R., Tremblay M., and Tremblay J.P. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J. Clin. Invest. 93 (1994) 586-599
39. Huard J., Cao B., and Qu-Petersen Z. Muscle-derived stem cells: Potential for muscle regeneration. Birth Defects Res. Part C Embryo Today 69 (2003) 230-237
40. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., and Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355 (1992) 696-702
41. Ito H., Hallauer P.L., Hastings K.E., and Tremblay J.P. Prior culture with concanavalin A increases intramuscular migration of transplanted myoblast. Muscle Nerve 21 (1998) 291-297
42. Jackson K.A., Mi T., and Goodell M.A. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sci. USA 96 (1999) 14482-14486
43. Jankowski R.J., Haluszczak C., Trucco M., and Huard J. Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: Potential for rapid isolation of muscle-derived stem cells. Hum. Gene Ther. 12 (2001) 619-628
44. Jankowski R.J., Deasy B.M., Cao B., Gates C., and Huard J. The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J. Cell Sci. 115 (2002) 4361-4374
45. Jankowski R.J., Deasy B.M., and Huard J. Muscle-derived stem cells. Gene Ther. 9 (2002) 642-647
46. Jankowski R.J., and Huard J. Establishing reliable criteria for isolating myogenic cell fractions with stem cell properties and enhanced regenerative capacity. Blood Cells Mol. Dis. 32 (2004) 24-33
47. Karpati G., Pouliot Y., Zubrzycka-Gaarn E., Carpenter S., Ray P.N., Worton R.G., and Holland P. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am. J. Pathol. 135 (1989) 27-32
48. Karpati G., Ajdukovic D., Arnold D., Gledhill R.B., Guttmann R., Holland P., Koch P.A., Shoubridge E., Spence D., Vanasse M., Watlers G.V., Abraharnowicz M., Duff C., and Worton R.G. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 34 (1993) 8-17
49. Kimura S., Ikezawa M., Pruchnic R., Balkir L., Qu Z., Lowenstein J., Takeda S., Gates C., Cao B., Miike T., and Huard J. Persistent gene transfer to skeletal muscle mediated by stably transfected early myogenic progenitor cells. Basic Appl. Myol. 10 (2000) 237-248
50. Kinoshita I., Vilquin J.T., Guerette B., Asselin I., Roy R., and Tremblay J.P. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 17 (1994) 1407-1415
51. Labrecque C., Roy R., and Tremblay J.P. Immune reactions after myoblast transplantation in mouse muscles. Transplant. Proc. 24 (1992) 2889-2892
52. Law P.K., Goodwin T.G., and Wang M.G. Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle Nerve 11 (1988) 525-533
53. Law P.K., Bertorini T.E., Goodwin T.G., Chen M., Fang Q.W., Li H.J., Kirby D.S., Florendo J.A., Herrod H.G., and Golden G.S. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 336 (1990) 114-115
54. Lee J.Y., Qu-Petersen Z., Cao B., Kimura S., Jankowski R., Cummins J., Usas A., Gates C., Robbins P., Wernig A., and Huard J. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J. Cell Biol. 150 (2000) 1085-1100
55. Lochmuller H., Petrof B.J., Pari G., Larochelle N., Dodelet V., Wang Q., Allen C., Prescott S., Massie B., Nalbantoglu J., and Karpati G. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Ther. 3 (1996) 706-716
56. Mammolenti M., Gajavelli S., Tsoulfas P., and Levy R. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro. Stem Cells 22 (2004) 1101-1110
57. Matsumura K., Ervasti J.M., Ohlendieck K., Kahl S.D., and Campbell K.P. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360 (1992) 588-591
58. Matsumura K., and Campbell K.P. Dystrophin-glycoprotein complex: Its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17 (1994) 2-15
59. McGeachie J.K., and Grounds M.D. Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice. An autoradiographic study. Cell Tissue Res. 248 (1987) 125-130
60. Mendell J.R., Kissel J.T., Amato A.A., King W., Signore L., Prior T.W., Sahenk Z., Benson S., McAndrew P.E., Rice R., Nagaraja H., Stephens R., Lantry L., Morris G.E., and Burghes A.M. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333 (1995) 832-838
61. Menke A., and Jockusch H. Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature 349 (1991) 69-71
62. Miranda A.F., Bonilla E., Martucci G., Moraes C.T., Hays A.P., and Dimauro S. Immunocytochemical study of dystrophin in muscle cultures from patients with Duchenne muscular dystrophy and unaffected control patients. Am. J. Pathol. 132 (1988) 410-416
63. Molnar G., Ho M.L., and Schroedl N.A. Evidence for multiple satellite cell populations and a non-myogenic cell type that is regulated differently in regenerating and growing skeletal muscle. Tissue Cell 28 (1996) 547-556
64. Morgan J.E., Hoffman E.P., and Partridge T.A. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J. Cell Biol. 111 (1990) 2437-2449
65. Morgan J.E., Pagel C.N., Sherratt T., and Partridge T.A. Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice. J. Neurol. Sci. 115 (1993) 191-200
66. Musgrave D.S., Bosch P., Lee J.Y., Pelinkovic D., Ghivizzani S.C., Whalen J., Niyibizi C., and Huard J. Ex vivo gene therapy to produce bone using different cell types. Clin. Orthop. 378 (2000) 90-305
67. Ohtsuka Y., Udaka K., Yamashiro Y., Yagita H., and Okumura K. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: Implication for gene therapy. J. Immunol. 160 (1998) 4635-4640
68. Olguin H.C., and Olwin B.B. Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: A potential mechanism for self-renewal. Dev. Biol. 275 (2004) 375-388
69. Oustanina S., Hause G., and Braun T. Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification. EMBO J. 23 (2004) 3430-3439
70. Ozawa E., Yoshida M., Suzuki A., Mizuno Y., Hagiwara Y., and Noguchi S. Dystrophin-associated proteins in muscular dystrophy. Hum. Mol. Genet. 4 Spec No (1995) 1711-1716
71. Partridge T.A., Morgan J.E., Coulton G.R., Hoffman E.P., and Kunkel L.M. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337 (1989) 176-179
72. Qu Z., Balkir L., van Deutekom J.C., Robbins P.D., Pruchnic R., and Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J. Cell Biol. 142 (1998) 1257-1267
73. Qu Z., and Huard J. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy. Gene Ther. 7 (2000) 428-437
74. Quinlan J.G., Lyden S.P., Cambier D.M., Johnson S.R., Michaels S.E., and Denman D.L. Radiation inhibition of mdx mouse muscle regeneration: Dose and age factors. Muscle Nerve 18 (1995) 201-206
75. Qu-Petersen Z., Deasy B., Jankowski R., Ikezawa M., Cummins J., Pruchnic R., Mytinger J., Cao B., Gates C., Wernig A., and Huard J. Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration. J. Cell Biol. 157 (2002) 851-864
76. Rando T.A., and Blau H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125 (1994) 1275-1287
77. Richler C., and Yaffe D. The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev. Biol. 23 (1970) 1-22
78. Sampaolesi M., Torrente Y., Innocenzi A., Tonlorenzi R., D'Antona G., Pellegrino M.A., Barresi R., Bresolin N., De Angelis M.G., Campbell K.P., Bottinelli R., and Cossu G. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301 (2003) 487-492
79. Satoh A., Huard J., Labrecque C., and Tremblay J.P. Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts. J. Histochem. Cytochem. 41 (1993) 1579-1582
80. Schultz E. Satellite cell proliferative compartments in growing skeletal muscles. Dev. Biol. 175 (1996) 84-94
81. Seale P., and Rudnicki M.A. A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev. Biol. 218 (2000) 115-124
82. Seale P., Sabourin L.A., Girgis-Gabardo A., Mansouri A., Gruss P., and Rudnicki M.A. Pax7 is required for the specification of myogenic satellite cells. Cell 102 (2000) 777-786
83. Shen H.C., Peng H., Usas A., Gearhart B., Cummins J., Fu F.H., and Huard J. Ex vivo gene therapy-induced endochondral bone formation: Comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. Bone 34 (2004) 982-992
84. Shen H.C., Peng H., Usas A., Gearhart B., Fu F.H., and Huard J. Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. J. Gene Med. 6 (2004) 984-991
85. Smythe G.M., Fan Y., and Grounds M.D. Enhanced migration and fusion of donor myoblasts in dystrophic and normal host muscle. Muscle Nerve 23 (2000) 560-574
86. Torrente Y., El Fahime E., Caron N.J., Bresolin N., and Tremblay J.P. Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases. Cell Transplant. 9 (2000) 539-549
87. Torrente Y., Tremblay J.P., Pisati F., Belicchi M., Rossi B., Sironi M., Fortunato F., El Fahime M., D'Angelo M.G., Caron N.J., Constantin G., Paulin D., Scarlato G., and Bresolin N. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J. Cell Biol. 152 (2001) 335-348
88. Torrente Y., Camirand G., Pisati F., Belicchi M., Rossi B., Colombo F., El Fahime M., Caron N.J., Issekutz A.C., Constantin G., Tremblay J.P., and Bresolin N. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. J. Cell Biol. 162 (2003) 511-520
89. Tremblay J.P., Malouin F., Roy R., Huard J., Bouchard J.P., Satoh A., and Richards C.L. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2 (1993) 99-112
90. Vilches C., and Parham P. KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20 (2002) 217-251
91. Vilquin J.T., Wagner E., Kinoshita I., Roy R., and Tremblay J.P. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J. Cell Biol. 131 (1995) 975-988
92. Wakeford S., Watt D.J., and Partridge T.A. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 14 (1991) 42-50
93. Watkins S.C., Hoffman E.P., Slayter H.S., and Kunkel L.M. Immunoelectron microscopic localization of dystrophin in myofibres. Nature 333 (1988) 863-866
94. Watt D.J., Lambert K., Morgan J.E., Partridge T.A., and Sloper J.C. Incorporation of donor muscle precursor cells into an area of muscle regeneration in the host mouse. J. Neurol. Sci. 57 (1982) 319-331
95. Watt D.J., Morgan J.E., and Partridge T.A. Use of mononuclear precursor cells to insert allogeneic genes into growing mouse muscles. Muscle Nerve 7 (1984) 741-750
96. Yoshida N., Yoshida S., Koishi K., Masuda K., and Nabeshima Y. Cell heterogeneity upon myogenic differentiation: Down-regulation of MyoD and Myf-5 generates 'reserve cells.'. J. Cell Sci. 111 Pt. 6 (1998) 769-779
97. Zammit P., and Beauchamp J. The skeletal muscle satellite cell: Stem cell or son of stem cell?. Differentiation 68 (2001) 193-204
98. Zammit P.S., Golding J.P., Nagata Y., Hudon V., Partridge T.A., and Beauchamp J.R. Muscle satellite cells adopt divergent fates: A mechanism for self-renewal?. J. Cell Biol. 166 (2004) 347-357
99. Zubrzycka-Gaarn E.E., Bulman D.E., Karpati G., Burghes A.H., Belfall B., Klamut H.J., Talbot J., Hodges R.S., Ray P.N., and Worton R.G. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333 (1988) 466-469